Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

BACKGROUND: Bixalomer (BXL) was developed to improve gastrointestinal symptoms and reduce constipation, relative to sevelamer hydrochloride, in hemodialysis patients. We prospectively evaluated the safety and effectiveness of switching maintenance dialysis patients from sevelamer hydrochloride to BX...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hatakeyama, Shingo, Murasawa, Hiromi, Narita, Takuma, Oikawa, Masaaki, Fujita, Naoki, Iwamura, Hiromichi, Mikami, Joutaro, Kojima, Yuta, Sato, Tendo, Fukushi, Ken, Ishibashi, Yusuke, Hashimoto, Yasuhiro, Koie, Takuya, Saitoh, Hisao, Funyu, Tomihisa, Ohyama, Chikara
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852730/
https://ncbi.nlm.nih.gov/pubmed/24119202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-14-222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados